News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
Presentation TCT 2019 AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation Presenter: Amit Vora September 28, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
Presentation TCT 2019 AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome Presenter: Stephan Windecker September 26, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019